BioCentury
ARTICLE | Financial News

Neurology company Denali updates IPO plans

December 1, 2017 10:02 PM UTC

Neurology play Denali Therapeutics Inc. (South San Francisco, Calif.) amended its proposed IPO on Nov. 27 and now plans to sell 8.3 million shares at $17-$19. At $18, the company would raise $150 mil...

BCIQ Company Profiles

Denali Therapeutics Inc.